|
1
|
|
|
2
|
- The advantages of micro/nanoscale instruments
- Cellular complexity
- The need for closed-loop control
- How to identify early manifestations of disease
- Modeling
- Interactive, dynamical analysis
- Mining dynamics data
|
|
3
|
- The advantages of micro/nanoscale instruments
- Cellular complexity
- The need for closed-loop control
- How to identify early manifestations of disease
- Modeling
- Interactive, dynamical analysis
- Mining dynamics data
|
|
4
|
|
|
5
|
- X-Ray / SEM / STM
- Optical microscope
- Magnifying glass
- Unaided eye
|
|
6
|
|
|
7
|
- I. The explosion in genomic and
proteomic knowledge and measurement techniques will revolutionize the
early detection of diseases
- II. Much of the potential lies in
the clinical implementation of the instrumentation and techniques that
provided the scientific foundation for genomics and proteomics
|
|
8
|
- Analysis of biofluids
- Molecular profiles that define biological states (Dahl)
- Disposable plastic lab-on-a-chip devices for point-of-care systems (Luke Lee)
- Indwelling biosensors and analyzers (Stephen C. Lee)
- Chemokine and cytokine expression (Barrett Rollins; Philip R. Streeter)
- Gene expression patterns (Carl W. Cotman; Marti Jett)
- Detection of mutant alleles (Helmut Zarbl)
- Protein expression/distribution (Philip R. Streeter; Gordon R.
Whiteley)
- Single-pass analysis of proteins, cells and tissues
- Detection of small numbers of molecules (Roger Brent)
- Multispectral cellular imaging (David Basiji)
- Protein distribution in tissues (Richard Caprioli)
- Interactive cellular assays for systems biology
- Disease/pathogen-induced changes in cells (Christopher Chen)
- Nanoscale sensing of single molecule binding (Michael Roukes)
- Massively Parallel, Multi-Phasic Cellular Biological activity detectors
(John Wikswo)
|
|
9
|
- Analysis of biofluids
- Molecular profiles that define biological states (Dahl)
- Disposable plastic lab-on-a-chip devices for point-of-care systems (Luke Lee)
- Indwelling biosensors and analyzers (Stephen C. Lee)
- Chemokine and cytokine expression (Barrett Rollins; Philip R. Streeter)
- Gene expression patterns (Carl W. Cotman; Marti Jett)
- Detection of mutant alleles (Helmut Zarbl)
- Protein expression/distribution (Philip R. Streeter; Gordon R.
Whiteley)
- Single-pass analysis of cells and tissues
- Detection of small numbers of molecules (Roger Brent)
- Multispectral cellular imaging (David Basiji)
- Protein distribution in tissues (Richard Caprioli)
- Key Features:
- Low temporal bandwidth sensing
- Slow events, long measurement intervals or single-pass imaging
- Semi-standard, static biochemical analyses
- Feature correlation and pattern recognition
- Will benefit directly from advances in genomics and proteomics
- May involve significant issues in bioinformatics
- Will benefit from Micro/Nano
|
|
10
|
- BioMicroElectroMechanical Systems (BioMEMS)
- Low-cost mass production
- Automated analysis
- Reduced instrument footprint
- Single instruments are very, very small
- Reduced volumes of analyte and reagents
- Massively parallel
- Increased data
- Lower cost per datum
- Combinatorics for frontal assault on multivariable systems
- Enabling new physical/chemical properties
- Single molecule detection
- Quantum dots
|
|
11
|
- ~2,000 valves to control
- Reagents
- Samples
- Wash steps
- www.fluidigm.com
|
|
12
|
|
|
13
|
|
|
14
|
|
|
15
|
|
|
16
|
- The advantages of micro/nanoscale instruments
- Cellular complexity
- The need for closed-loop control
- How to identify early manifestations of disease
- Modeling
- Interactive, dynamical analysis
- Mining dynamics data
|
|
17
|
- III. Historically, dynamical
studies of cellular metabolism and signaling pathways have been limited
by the bandwidth of laboratory biochemistry
- IV. BioMicroElectroMechanical
Systems (BioMEMS) offer promise to extend the measurement bandwidth for
both research and clinical diagnosis
|
|
18
|
- Interactive cellular assays for systems biology
- Disease/pathogen-induced changes in cells (Christopher Chen)
- Nanoscale sensing of single molecule binding (Michael Roukes)
- Massively Parallel, Multi-Phasic Cellular Biological Activity Detectors
(John Wikswo)
- Key Features:
- More closely related to experimental physiology than classical clinical
biochemistry
- Can involve rapid sensing of physiological dynamics
- Measurement bandwidth << physiological bandwidth
- Real-time intervention is REQUIRED to probe the dynamics
- Internal vs. external feedback
- “Bandwidth is everything”
- May require models for interpretation of complex interactions
- There may be significant computational contraints to multiscale
dynamical models
|
|
19
|
|
|
20
|
- Physiology is dynamic
- Cell cycle
- Developmental differentiation
- Growth
- Voltage- and ligand-gates ion channels
- Propagating waves
- Signaling cascades
- Closed-loop feedback and control
|
|
21
|
- Courtesy of Christian Schmidt and Will Lachnit
|
|
22
|
- Courtesy of Ananta Krishnan, DARPA
|
|
23
|
- Mixing time to homogenize liquid in a large-scale bioreactor (10-100 m3) 104 -108
- 90% liquid volume exchange in in a continuous reactor 105 -106
- Oxygen transfer (forced not free diffusion) 102 -103
- Heat transfer (forced convection) 103 - 104
- Cell proliferation, DNA replication 102 -104
- Response to environmental changes (temperature, oxygen) 103 -104
- Messenger RNA synthesis 103 -104
- Translocation of substances into cells (active transport) 101 -103
- Protein synthesis 101 -102
- Allosteric control of enzyme action 1
- Glycolysis 10-1 -10-2
- Oxidative phosphorylation in mitochondria 10-2
- Intracellular quiescent mass & heat transfer (dimension 10-5
m) 10-5 -10-3
- Enzymatic reaction and turnover 10-6 -10-3
- Bonding between enzyme & substrate, inhibitor 10-6
- Receptor-ligand interaction 10-6
|
|
24
|
- Use experimental measurements, numerical simulations, and knowledge of
the genome and proteome to unravel the complex, multiscale interactions
and dynamics in normal physiology, toxic exposures, and disease
- Metabolic networks
- Intracellular and extracellular signaling
- Gene expression
- Protein interactions
- Cell-cell interactions
- Active transport
- Development, growth, aging, death
|
|
25
|
|
|
26
|
- Specify concentrations and
- Rate constants
- Add gene expression,
- Protein interactions, and
- Signaling pathways;
- Include intracellular spatial distributions, diffusion, and transport,
- … and calculate how the target cell behaves in response to a toxin or
pathogen
|
|
27
|
|
|
28
|
|
|
29
|
|
|
30
|
- Modeling of a single mammalian cell may require 100,000 variables and
equations
- Cell-cell interactions are critical to system function
- 109 interacting cells in some organs
- Models may be leibnitz-class
- The data don’t yet exist to drive the models!
- Hence we need to experiment…
- *1 leibnitz = 1 mole of PDEs ~ 1 etaFLOPS-year
|
|
31
|
- The advantages of micro/nanoscale instruments
- Cellular complexity
- The need for closed-loop control
- How to identify early manifestations of disease
- Modeling
- Interactive, dynamical analysis
- Mining dynamics data
|
|
32
|
- Most chemical and metabolic sensors and actuators
- Are too slow to track biochemical events at the cellular level
- Are made one at a time
- Biological systems contain extensive closed-loop, multilevel, feedback
and control
- Simple, single-step observations cannot discern how control is
distributed through the system.
- Closed-loop metabolic control is today possible only at the animal and
organ level, e.g., glucose clamp
- Chemical control is limited by diffusion, stirring, uncaging rates, or
the time required to move a cell from one medium to another
- Post-genomic physiology needs multiparameter, wide-bandwidth cellular
metabolic and signaling sensing and control
|
|
33
|
- Simultaneous, fast sensors
(transducers) that detect a variety of
changes within and
outside the cell
- Actuators that control the
microenvironment within and outside the cell
- Openers for the internal feedback loops
- System algorithms and models that allow you to close and stabilize the
external feedback loop
- …
|
|
34
|
- Develop the tools and techniques for integrative, post-genomic cellular
biology
- Genes
- Proteins
- Metabolic and signaling pathways
- Instruments
- Models
- Wide-bandwidth dynamic control theory for cellular systems
- How do normal and diseased cells function?
|
|
35
|
- Arrays of instrumented single or multiple cells: Rapid, sensitive, and accurate
differential diagnosis of cellular pathophysiology
- Cellular dynamics: Discrimination between causal and secondary events
- Functional biopsy: Determine the state of specific physiological
pathways and mechanisms affected by an as-yet undetected disease, and
thus define a prophylaxis or therapy.
- Artificial, minimal cells: engineered to serve as dedicated,
configurable, robust on-chip biosensors.
- “Quantitative physiology at the
speed of life,” C. Kovac
|
|
36
|
- A biological cell or molecule inserted into a microinstrument, e.g., a
single-cell spectrophotometer or a whole-cell patch clamp
- A nanoinstrument inserted into the cell/molecule, e.g., caged ATP
- Combine the two approaches to form an FAST integrated, closed-loop
bio/nano/micro system
|
|
37
|
- Goal – utilize proven gigaOhm seals to biological membranes
- Result – high-speed microfluidics and silicon microelectronics can be
placed “inside” a living cell
|
|
38
|
- V. Great advances in physiology
have been made through opening physiological feedback loops and applying
external control
- Frank-Starling cardiovascular regulation
- Glucose/insulin regulation
- Hodgkin-Huxley model of the nerve action potential
- VI. There will exist a class of
diseases or susceptibilities to drugs or toxins that can be diagnosed
through altered cellular dynamics
|
|
39
|
- Mixing time to homogenize liquid in a large-scale bioreactor (10-100 m3) 104 -108
- 90% liquid volume exchange in in a continuous reactor 105 -106
- Oxygen transfer (forced not free diffusion) 102 -103
- Heat transfer (forced convection) 103 - 104
- Cell proliferation, DNA replication 102 -104
- Response to environmental changes (temperature, oxygen) 103 -104
- Messenger RNA synthesis 103 -104
- Translocation of substances into cells (active transport) 101 -103
- Protein synthesis 101 -102
- Allosteric control of enzyme action 1
- Glycolysis 10-1 -10-2
- Oxidative phosphorylation in mitochondria 10-2
- Intracellular quiescent mass & heat transfer (dimension 10-5
m) 10-5 -10-3
- Enzymatic reaction and turnover 10-6 -10-3
- Bonding between enzyme & substrate, inhibitor 10-6
- Receptor-ligand interaction 10-6
|
|
40
|
- Wide measurement bandwidth, i.e., good
response to high frequencies, is required to track fast cellular
events
- Stable control of fast systems requires high bandwidth
- Small is the best way to beat the time for diffusional mixing in
large-scale assays
- Small lets one look at individual cellular events rather than ensemble
averages
|
|
41
|
|
|
42
|
- Electrochemical sensitivity scale-invarient; frequency response improves
as size is decreased
- Decreased mixing times for mass and heat transfer
- Reduced reagent volumes for rapid injection
- Many nanocultures within a single device
- Monitor known, small (N=1?) number of cells in each nanoculture
- Array of NanoBioReactors, in parallel, in series, and with redundancy
for high-content screening
|
|
43
|
- Sensors: Advanced micro and
nanosensors can quantify the extra- cellular and
intra-cellular
environments with unprecedented temporal
resolution
- Actuators: Microfluidics can control extracellular and intracellular
concentrations of key chemicals with millisecond-response picoliter
pumps
- Openers: RNAi, genetic knockouts, and blockers will allow opening of the
internal feedback loop
- Controllers: It will be possible to create high-speed extracellular and
intracellular chemical clamps functionally equivalent to voltage clamp
for Vm
|
|
44
|
- Vanderbilt University
- Departments of Biomedical Engineering, Chemical Engineering, Chemistry,
Mechanical Engineering, Molecular Physiology & Biophysics, Physics
& Astronomy
|
|
45
|
|
|
46
|
|
|
47
|
|
|
48
|
|
|
49
|
|
|
50
|
- Courtesy of Ananta Krishnan, DARPA
|
|
51
|
|
|
52
|
- The advantages of micro/nanoscale instruments
- Cellular complexity
- The need for closed-loop control
- How to identify early manifestations of disease
- Modeling
- Interactive, dynamical analysis
- Mining dynamics data
|
|
53
|
|
|
54
|
|
|
55
|
|
|
56
|
|
|
57
|
- Micro/Nano will “increase throughput and automation, reducing cost per
analysis, and enabling entirely new applications.” C. Dahl
- Understanding cellular dynamics is key to understanding cellular physiology
- Micro/Nano will enable closed-loop control of certain cellular functions
- Biology and biochemistry can serve as preamplifiers for biological,
biochemical, and biophysical detectors
- PCR of course, but what else?
- Cell harvesting may be a problem for many tissues
- Physiological biopsy
- Pretransplant certification (pancreatic beta cells in islet
transplants)
- Well suited for probing drug interactions for particular phenotypes
- Dynamic model complexity is a major challenge
- Specification
- Verification
|